chemXplore tracks 13 projects in Russian Federation, of which 7 are active.
Of the active ones, 5 new construction, 1 expansion and 1 revamp / retrofit.
The guidance covers certain transactions involving Lukoil or Litasco and runs until 19 March 2027.
Permits transfer of Russian‑issued securities and related Russian approvals; valid until 28 February 2027; does not permit final divestment without separate OFAC authorisation.
Improved export margins and record lubricants profits drove quarter; battery unit loss narrowed despite lower sales, while ESS orders and LFP supply deals in North America strengthen outlook.
EBITDA fell to NOK 554 million in Q3 2026 as weak silicon prices hit results; foundry alloys and carbon outperformed and new EU trade measures and allowances improve the outlook.
Revenue largely flat; operating income hit by Russia deconsolidation and Pakistan divestment. Net cash from operations €187m and full-year adjusted EBITDA guided to about €1.47bn.
An indirect, covariate‑adjusted comparison of SURMOUNT‑1 and STEP UP data shows larger mean and categorical weight‑loss benefits with tirzepatide 10 mg and 15 mg at 72 weeks.
Framework to boost EU production capacity, guide R&D and investments, and reduce dependence on Russian isotopes and HALEU.
London tribunal upholds suspension due to sanctions, orders ~€260m to Tecnimont, rejects €1.6bn counterclaims; Phase 2 will consider injunctions and extra damages.
Transfer of a 10% Arctic LNG 2 stake to NordLine completed; TotalEnergies retains claim for about US$1.3bn in shareholder loans, subject to sanctions.
Defines governance and decision-making for NIS, secures Pancevo refinery operation and market supply with a 10‑year capacity commitment, but closing awaits seller agreement and OFAC approval.